Regulus' microRNA Proves Attractive to GSK
By Sally Mardikian PhD
Pharma Deals Review: Vol 2008 Issue 94 (Table of Contents)
Published: 17 Apr-2008
DOI: 10.3833/pdr.v2008.i94.186 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
GSK is another big pharma looking at the potential of RNAi technologies in this deal with Regulus...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS